Brown & Brown Operating Cash Flow decreased by 41.0% to $262.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.0%, from $213.00M to $262.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 15.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $138.00M | $241.90M | $247.90M | $181.00M | $103.60M | $242.60M | $253.60M | $281.20M | $60.00M | $328.00M | $316.00M | $306.00M | $13.00M | $360.00M | $440.00M | $361.00M | $213.00M | $325.00M | $468.00M | $444.00M | $262.00M |
| QoQ Change | — | +75.3% | +2.5% | -27.0% | -42.8% | +134.2% | +4.5% | +10.9% | -78.7% | +446.7% | -3.7% | -3.2% | -95.8% | >999% | +22.2% | -18.0% | -41.0% | +52.6% | +44.0% | -5.1% | -41.0% |
| YoY Change | — | — | — | — | -24.9% | +0.3% | +2.3% | +55.4% | -42.1% | +35.2% | +24.6% | +8.8% | -78.3% | +9.8% | +39.2% | +18.0% | >999% | -9.7% | +6.4% | +23.0% | +23.0% |